Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Cancer research, Medicine, Transcription factor, KRAS, Lung cancer, and Biology.
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
Activation of GATA binding protein 6 ( <i>GATA6</i> ) sustains oncogenic lineage-survival in esophageal adenocarcinoma
The Hedgehog processing pathway is required for NSCLC growth and survival